CAPRELSA
CAPRELSA
Approved
DIN Number
02378582
Drug Class
Human
Market Date
Feb 23, 2012
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02378582
AIG Number0153066001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01EX04 VANDETANIB
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
VANDETANIBActive
Strength: 100 MG
Monograph: VANDETANIB